Strax Q3 2022: Steps in the right direction
Research Update
2022-11-28
07:30
Management continues to execute according to its action list, having divested two brands plus its licensing business in Q3. It aims to sell its Health & Wellness business in the coming two to four months. Having cut revenues and EBIT by around 7%, Redeye adjust Base Case only marginally to SEK2.9.
FR
JVK
Fredrik Reuterhäll
Jesper Von Koch
Disclosures and disclaimers